Mohammed Mahbubul Matin

Prof. Dr. Mohammed Mahbubul Matin

University of Chittagong, Chittagong, Bangladesh
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
Mohammed Mahbubul MatinMohammed Mahbubul Matin
Mohammed Mahbubul Matin
PMPriyanka Matin
Priyanka Matin
RRRezaur Rahman
Rezaur Rahman
THTaibi Ben Hadda
Taibi Ben Hadda
FAFaisal A. Almalki
Faisal A. Almalki
SASultan Alshehri
Sultan Alshehri
Among the nitrogen-containing heterocyclic compounds, triazoles emerge with superior pharmacological applications. Structurally, there are two types of five-membered triazoles: 1,2,3-triazole and 1,2,4-triazole. Due to the structural characteristics, both 1,2,3- and 1,2,4-triazoles are able to accommodate a broad range of substituents (electrophiles and nucleophiles) around the core structures and pave the way for the construction of diverse novel bioactive molecules. Both the triazoles and their derivatives have significant biological properties including antimicrobial, antiviral, antitubercular, anticancer, anticonvulsant, analgesic, antioxidant, anti-inflammatory, and antidepressant activities. These are also important in organocatalysis, agrochemicals, and materials science. Thus, they have a broad range of therapeutic applications with ever-widening future scope across scientific disciplines. However, adverse events such as hepatotoxicity and hormonal problems lead to a careful revision of the azole family to obtain higher efficacy with minimum side effects. This review focuses on the structural features, synthesis, and notable therapeutic applications of triazoles and related compounds.

1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BIBadrul Islam
Badrul Islam
IIInshaful Islam
Inshaful Islam
NNNikhil Nath
Nikhil Nath
TETalha Bin Emran
Talha Bin Emran
MRMd. Rezaur Rahman
Md. Rezaur Rahman
Mohammed Mahbubul MatinMohammed Mahbubul Matin
Mohammed Mahbubul Matin
Multidrug‐resistant (MDR) pathogens have created a fatal problem for human health and antimicrobial treatment. Among the currently available antibiotics, many are inactive against MDR pathogens. In this context, heterocyclic compounds/drugs play a vital role. Thus, it is very much essential to explore new research to combat the issue. Of the available nitrogen‐bearing heterocyclic compounds/drugs, pyridine derivatives are of special interest due to their solubility. Encouragingly, some of the newly synthesized pyridine compounds/drugs are found to inhibit multidrug‐resistant S. aureus (MRSA). Pyridine scaffold bearing poor basicity generally improves water solubility in pharmaceutically potential molecules and has led to the discovery of numerous broad‐spectrum therapeutic agents. Keeping these in mind, we have reviewed the chemistry, recent synthetic techniques, and bacterial preventative activity of pyridine derivatives since 2015. This will facilitate the development of pyridine‐based novel antibiotic/drug design in the near future as a versatile scaffold with limited side effects for the next‐generation therapeutics.

1 January 2021 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
MUMonir Uzzaman
Monir Uzzaman
KHKamrul Hasan
Kamrul Hasan
SMShafi Mahmud
Shafi Mahmud
KFKaniz Fatema
Kaniz Fatema
Mohammed Mahbubul MatinMohammed Mahbubul Matin
Mohammed Mahbubul Matin

10 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HKHARSH KUMAR
HARSH KUMAR
NANavidha Aggarwal
Navidha Aggarwal
MMMinakshi Gupta Marwaha
Minakshi Gupta Marwaha
ADAakash Deep
Aakash Deep
HCHITESH CHOPRA
HITESH CHOPRA
Ahmed Al-HarrasiAhmed Al-Harrasi
Ahmed Al-Harrasi
Heterocyclic compounds containing nitrogen and sulfur, especially those in the thiazole family, have generated special interest in terms of their synthetic chemistry, which is attributable to their ubiquitous existence in pharmacologically dynamic natural products and also as overwhelmingly powerful agrochemicals and pharmaceuticals. The thiazolidin-2,4-dione (TZD) moiety plays a central role in the biological functioning of several essential molecules. The availability of substitutions at the third and fifth positions of the Thiazolidin-2,4-dione (TZD) scaffold makes it a highly utilized and versatile moiety that exhibits a wide range of biological activities. TZD analogues exhibit their hypoglycemic activity by improving insulin resistance through PPAR-γ receptor activation, their antimicrobial action by inhibiting cytoplasmic Mur ligases, and their antioxidant action by scavenging reactive oxygen species (ROS). In this manuscript, an effort has been made to review the research on TZD derivatives as potential antimicrobial, antioxidant, and antihyperglycemic agents from the period from 2010 to the present date, along with their molecular mechanisms and the information on patents granted to TZD analogues.

1 December 2020 in Journal of Molecular Structure
Verified
Journal Article
Closed access
Mohammed Mahbubul MatinMohammed Mahbubul Matin
Mohammed Mahbubul Matin
SHS. Hasan
S. Hasan
MUMonir Uzzaman
Monir Uzzaman
MBMosharef H. Bhuiyan
Mosharef H. Bhuiyan
SKSayed M. Kibria
Sayed M. Kibria
MRMohammad H.O. Roshid
Mohammad H.O. Roshid

10 December 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Mohammed Mahbubul MatinMohammed Mahbubul Matin
Mohammed Mahbubul Matin
MUMonir Uzzaman
Monir Uzzaman
SCShagir Ahammad Chowdhury
Shagir Ahammad Chowdhury
MBMosharef Hossain Bhuiyan
Mosharef Hossain Bhuiyan
Different esters were found potential against microorganisms, and could be a better choice to solve the multidrug resistant (MDR) pathogenic global issue due to their improved biological and pharmacokinetic properties. In this view, several 4-t-butylbenzoyl uridine esters 4–15 with different aliphatic and aromatic groups were synthesized for antimicrobial, physicochemical and biological studies. In vitro antimicrobial tests against nine bacteria and three fungi along with prediction of activity spectra for substances (PASS) indicated promising antifungal functionality of these uridine esters compared to the antibacterial activities. In support of this observation their cytotoxicity and molecular docking studies have been performed against lanosterol 14α-demethylase (CYP51A1) and Aspergillus flavus (1R51). Significant binding affinities were observed against SARS-CoV-2 main protease (7BQY) considering hydroxychloroquine (HCQ) as standard. ADMET predictions were investigated to evaluate their absorption, metabolism and toxic properties. Most of the uridine esters showed better results than that of the HCQ. Overall, the present study might be useful for the development of uridine-based novel MDR antimicrobial and COVID-19 drugs. Graphical Abstract Communicated by Ramaswamy H. Sarma